However, this and other sulfonamide antibiotics are still frequently used to to treat urinary track infections and skin infections with MRSA

Testosterone Replacement Therapy: Nausea or vomiting Infertility or decreased sperm count Testicular shrinkage Worsening of obstructive sleep apnea Increase in cholesterol levels Abnormal spike in blood sugar levels, which can increase the risk of developing Type 2 diabetes Yellowing of the skin or around your eyes Uncomfortable swelling or enlargement of breast tissue (gynecomastia) Redness, warmth around lower leg area Unusual increase in red blood cell count, which can result in high blood pressure, joint/muscle pain, trouble with eyesight or thrombosis (blood clotting) Frequent need to urinate Fluid retention Acne or oily skin Headaches Lumps or hardening around injection site Clomid: Headaches Nausea Bloating Mood swings Diminished sex drive Sperm counts decrease (can be reversed by changing Clomid to another type of estrogen blocker, such as tamoxifen.) Acne Chest tenderness Blurry vision Weight gain High blood pressure (hypertension) Altered taste Asthma Flushing Excess thirst Joint aches Enclomiphene Libido issues Acne A temper if levels get too high Mood swings Depression Mood irritability Anxiety Gynecomastia Headache Nausea Diarrhea Dizziness Common Cold Hot flush Joint pain NOTE: Enclomiphene is the purified isomer of Clomid (Clomiphene Citrate)

Ozempic might be relevant if: You have type 2 diabetes its specifically licensed and effective for blood sugar control You want a weekly injection once-a-week dosing is more convenient than daily You prefer fewer side effects lower rates of nausea and gastrointestinal issues compared with liraglutide Note that if weight management is your primary goal, Ozempic isnt an appropriate choice as its not licensed for this purpose in the UK
Vitamin B12 is known for its energy-boosting properties, and when compounded with Semaglutide, it may enhance exercise performance and improve treatment tolerance, potentially leading to better outcomes in weight management
(2021) "Once-Weekly Semaglutide in Adults with Overweight or Obesity." Yin, J., Xing, H., & Ye, J
Early adoption of sodium-glucose cotransporter-2 inhibitor in patients hospitalized with heart failure with mildly reduced or preserved ejection fraction